Article

N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.

Department of Psychiatry, University of Minnesota School of Medicine, Minneapolis, MN 55454, USA.
Archives of general psychiatry (Impact Factor: 12.26). 08/2009; 66(7):756-63. DOI: 10.1001/archgenpsychiatry.2009.60
Source: PubMed

ABSTRACT Trichotillomania is characterized by repetitive hair pulling that causes noticeable hair loss. Data on the pharmacologic treatment of trichotillomania are limited to conflicting studies of serotonergic medications. N-acetylcysteine, an amino acid, seems to restore the extracellular glutamate concentration in the nucleus accumbens and, therefore, offers promise in the reduction of compulsive behavior.
To determine the efficacy and tolerability of N-acetylcysteine in adults with trichotillomania.
Twelve-week, double-blind, placebo-controlled trial.
Ambulatory care center.
Fifty individuals with trichotillomania (45 women and 5 men; mean [SD] age, 34.3 [12.1] years).
N-acetylcysteine (dosing range, 1200-2400 mg/d) or placebo was administered for 12 weeks.
Patients were assessed using the Massachusetts General Hospital Hair Pulling Scale, the Clinical Global Impression scale, the Psychiatric Institute Trichotillomania Scale, and measures of depression, anxiety, and psychosocial functioning. Outcomes were examined using analysis of variance modeling analyses and linear regression in an intention-to-treat population.
Patients assigned to receive N-acetylcysteine had significantly greater reductions in hair-pulling symptoms as measured using the Massachusetts General Hospital Hair Pulling Scale (P < .001) and the Psychiatric Institute Trichotillomania Scale (P = .001). Fifty-six percent of patients "much or very much improved" with N-acetylcysteine use compared with 16% taking placebo (P = .003). Significant improvement was initially noted after 9 weeks of treatment.
This study, the first to our knowledge that examines the efficacy of a glutamatergic agent in the treatment of trichotillomania, found that N-acetylcysteine demonstrated statistically significant reductions in trichotillomania symptoms. No adverse events occurred in the N-acetylcysteine group, and N-acetylcysteine was well tolerated. Pharmacologic modulation of the glutamate system may prove to be useful in the control of a range of compulsive behaviors.
clinicaltrials.gov Identifier: NCT00354770.

1 Bookmark
 · 
233 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Trichotillomania is characterized by repetitive pulling out of one's own hair. Impaired response inhibition has been identified in patients with trichotillomania, along with gray matter density changes in distributed neural regions including frontal cortex. The objective of this study was to evaluate impaired response inhibition and abnormal cortical morphology as candidate endophenotypes for the disorder. Subjects with trichotillomania (N = 12), unaffected first-degree relatives of these patients (N = 10), and healthy controls (N = 14), completed the Stop Signal Task (SST), a measure of response inhibition, and structural magnetic resonance imaging scans. Group differences in SST performance and cortical thickness were explored using permutation testing. Groups differed significantly in response inhibition, with patients demonstrating impaired performance versus controls, and relatives occupying an intermediate position. Permutation cluster analysis revealed significant excesses of cortical thickness in patients and their relatives compared to controls, in right inferior/middle frontal gyri (Brodmann Area, BA 47 & 11), right lingual gyrus (BA 18), left superior temporal cortex (BA 21), and left precuneus (BA 7). No significant differences emerged between groups for striatum or cerebellar volumes. Impaired response inhibition and an excess of cortical thickness in neural regions germane to inhibitory control, and action monitoring, represent vulnerability markers for trichotillomania. Future work should explore genetic and environmental associations with these biological markers.
    Journal of Psychiatric Research 09/2014; · 4.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Historically, trichotillomania (TTM) in young children (0–3 years old) generally has been considered to be a benign habit that is clinically distinct from the TTM seen in older children and adults. However, early childhood TTM can be an impairing pathological disorder that merits formal intervention. The present article reviews the extant literature on TTM in young children, highlighting the limited available phenomenological data. We discuss a behavioral approach to conceptualization and treatment, highlighting core intervention strategies in three early childhood TTM cases seen in our clinic. We conclude by discussing areas in need of further empirical attention.Históricamente, la tricotilomanía (TTM) en los niños pequeños (0-3 años de edad) ha sido generalmente considerada como un hábito benigno que es clínicamente distinto de la TTM que se observa en niños mayores y en adultos. Sin embargo, la TTM en la temprana niñez puede representar un trastorno patológico de impedimento que amerita una intervención formal. El presente estudio revisa la literatura aun existente en cuanto a TTM en los niños pequeños, haciendo sobresalir la limitada información fenomenológica disponible. Discutimos un acercamiento de conducta a la conceptualización y al tratamiento, subrayando las estrategias claves de intervención en tres casos de TTM en la temprana niñez, atendidos en nuestra clínica. Concluimos el estudio con una discusión de las áreas que necesitan una mayor atención empírica.Historiquement, la trichotillomania (TTM) chez les jeunes enfants (0-3 ans) a généralement été considérée comme étant une habitude bénigne, cliniquement distincte de la TTM vue chez les enfants plus âgés ou les adultes. Cependant la TTM durant a petite enfance peut s'avérer être un trouble pathologique handicapant qui exige une intervention formelle. Cet article passe en revue les recherches sur la TTM chez les jeunes enfants, mettant l'accent sur les données phénoménologiques limitées qui sont à notre disposition. Nous discutons l'approche comportementale de la conceptualisation et du traitement, mettant l'accent sur les stratégies d'intervention dans trois cas de TTM durant la petite enfance, vus dans notre clinique. Nous concluons en discutant les domaines nécessitant une attention empirique.Historisch wird Trichotillomanie (TTM) in der frühen Kindheit im Allgemeinen als eine gutartige Gewohnheit angesehen, die sich klinisch von TTM in älteren Kindern unterscheidet. Jedoch könnte sich TTM in der frühen Kindheit als eine belastende pathologische Störung erweisen, die formelle Intervention erfordert. Die vorliegende Arbeit gibt einen Überblick der vorhandenen Literatur zu TTM bei jungen Kindern und legt einen Schwerpunkt auf begrenzt verfügbare phänomenologische Daten. Es wird ein verhaltenstherapeutischer Ansatz zur Konzeptualisierung und Behandlung diskutiert, der die Kernstrategien zur Intervention anhand von drei Fällen mit TTM im frühen Kindesalter an unserer Klinik betont. Wir schließen die Arbeit mit einer Diskussion derjenigen Bereiche ab, die weiterer empirischer Forschung bedürfen.
    Infant Mental Health Journal 03/2012; 33(2). · 0.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Trichotillomania, or chronic hairpulling, is a common condition that affects primarily women. The disorder can cause significant psychosocial impairment and is associated with elevated rates of psychiatric comorbidity. In this article, the phenomenology, etiology, assessment, and treatment of the disorder are discussed.
    Psychiatric Clinics of North America 09/2014; · 2.13 Impact Factor

Preview

Download
8 Downloads
Available from